secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K
Filed at:   2023-07-12T23:59:59+00:00
Accession:  0001601830-23-000050
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Recursion secures $50M investment from NVIDIA; collaboration on AI drug discovery models
--------------------------------------------------------------------------------

- NVIDIA invested $50M via private placement of 7,706,363 shares at $6.488145/share.
- Recursion plans to develop and distribute AI foundation models using NVIDIA DGX Cloud and BioNeMo.
- Recursion's dataset exceeds 23 petabytes and 3 trillion searchable gene/compound relationships.
- Proceeds to fund clinical/preclinical programs, digital chemistry, and foundation model construction.
- Collaboration aims to optimize and scale biomolecular generative AI for biotech/pharma.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000160183023000050/0001601830-23-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000160183023000050/rxrx-20230711.htm
  HTML page:      https://secwatch.observer/filing/0001601830-23-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer